Past Economic Evaluation seminars 2014

Challenges for economic evaluation when doing research with people with learning disabilities

Wednesday 10 December 2014

Authors: C Hulme, J O’Dwyer, L Bryant, A Russell, AO House on behalf of the OK Diabetes Research Team

The synthetic control method compared to difference-in differences for evaluating health policies

Tuesday 4 November 2014

Noemi Kreif PhD, Research Fellow in Health Economics, London School of Hygiene and Tropical Medicine

Multi-criteria decision analysis (MCDA) of the adoption of biosimilars in oncology

Thursday 23 October 2014

Multi-criteria decision analysis (MCDA) of the adoption of biosimilars in oncology by Dennis W Raisch, Maarten Ijzermann, Charles L Bennett.

‘In with the old, out with the new’ – In search of ways to help health economists break their addiction to technology adoption

Friday 17 October 2014

Stirling Bryan

Future modelling of chronic diseases: foresight and beyond

Thursday 18 September 2014

Dr Martin Brown, UK Health Forum

Comparative hospital performance: new data, borrowed methods, more targeted analysis?

Tuesday 1 July 2014

Professor Jon Karnon, School of Population Health, University of Adelaide

HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and cost-effectiveness of increased HIV testing and earlier ART initiation

Wednesday 11 June 2014

Professor Andrew Phillips and Valentina Cambiano, University College London

An illustration of the usefulness of the multi-state model survival analysis approach for health economic evaluation modelling

Tuesday 27 May 2014

Dr Jim Lewsey, Health Economics and Health Technology Assessment, Institute of Health and Wellbeing, University of Glasgow

The EQ-5D: Is it fit for purpose in oncology trials?

Thursday 8 May 2014

Adam Smith, PhD. KTP Associate/Senior Research Fellow at York Health Economics Consortium Ltd

The Willingness to Pay for a QALY and type of disorder: a decision maker approach

Wednesday 9 April 2014

Mikael Svensson, PhD, Associate Professor in Economics, Karlstad University

Are we really including all relevant evidence? Considerations for network meta-analysis

Thursday 13 March 2014

Beth Woods

The many faces of multiplicity in HTA

Tuesday 4 March 2014

Dr Neil Hawkins, Honorary Professor, University of Glasgow, Icon PLC

Projecting ‘time to event’ outcomes in technology assessment: an alternative paradigm

Thursday 13 February 2014

Professor Adrian Bagust, University of Liverpool

Mechanism-based pharmacoeconomic modelling

Wednesday 15 January 2014

Professor Dyfrig Hughes, Centre for Health Economics and Medicines Evaluation, Bangor University